2:
Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).
Chew EY, Ambrosius WT, Howard LT, Greven CM, Johnson S, Danis RP, Davis MD, Genuth S, Domanski M; ACCORD Study Group.
Am J Cardiol. 2007 Jun 18;99(12A):103i-111i. Epub 2007 Apr 13.
PMID: 17599420 [PubMed - indexed for MEDLINE]
Related Articles
3:
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods.
Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ; ACCORD Study Group.
Am J Cardiol. 2007 Jun 18;99(12A):112i-122i. Epub 2007 Apr 12.
PMID: 17599421 [PubMed - indexed for MEDLINE]
Related Articles
4:
Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design.
Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Narayan KM, Nwachuku C, O'Connor PJ, Zhang P; ACCORD Study Group.
Am J Cardiol. 2007 Jun 18;99(12A):90i-102i. Epub 2007 Apr 13.
PMID: 17599429 [PubMed - indexed for MEDLINE]
Related Articles
10:
Cost effectiveness of ACE inhibitor treatment for patients with type 1 diabetes mellitus.
Dong FB, Sorensen SW, Manninen DL, Thompson TJ, Narayan V, Orians CE, Gregg EW, Eastman RC, Dasbach EJ, Herman WH, Newman JM, Narva AS, Ballard DJ, Engelgau MM.
Pharmacoeconomics. 2004;22(15):1015-27.
PMID: 15449965 [PubMed - indexed for MEDLINE]
Related Articles
13:
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.
Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.
PMID: 17599422 [PubMed - indexed for MEDLINE]
Related Articles
16:
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG; ACCORD Study Group.
Am J Cardiol. 2007 Jun 18;99(12A):80i-89i. Epub 2007 Apr 17.
PMID: 17599428 [PubMed - indexed for MEDLINE]
Related Articles